高级检索
当前位置: 首页 > 详情页

Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Tongji Univ, Shanghai East Hosp, Sch Med, Shanghai Inst Stem Cell Res & Clin Translat, Shanghai, Peoples R China [2]Tongji Univ, Tongji Hosp, Key Lab Spine & Spinal Cord Injury Repair & Regen, Minist Educ,Orthoped Dept,Sch Med, Shanghai, Peoples R China [3]Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China [4]Chinese Acad Sci, Ctr Biosafety Megasci, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, Wuhan, Peoples R China [5]Univ Chinese Acad Sci, Beijing, Peoples R China [6]Tongji Univ, Shanghai Peoples Hosp 4, Sch Med, Dept Endocrinol & Metab, Shanghai, Peoples R China
出处:
ISSN:

摘要:
Large-scale COVID-19 vaccinations are currently underway in many countries in response to the COVID-19 pandemic. Here, we report, besides generation of neutralizing antibodies, consistent alterations in hemoglobin A1c, serum sodium and potassium levels, coagulation profiles, and renal functions in healthy volunteers after vaccination with an inactivated SARS-CoV-2 vaccine. Similar changes had also been reported in COVID-19 patients, suggesting that vaccination mimicked an infection. Single-cell mRNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) before and 28 days after the first inoculation also revealed consistent alterations in gene expression of many different immune cell types. Reduction of CD8(+) T cells and increase in classic monocyte contents were exemplary. Moreover, scRNA-seq revealed increased NF-kappa B signaling and reduced type I interferon responses, which were confirmed by biological assays and also had been reported to occur after SARS-CoV-2 infection with aggravating symptoms. Altogether, our study recommends additional caution when vaccinating people with pre-existing clinical conditions, including diabetes, electrolyte imbalances, renal dysfunction, and coagulation disorders.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 2 区 生物
小类 | 2 区 细胞生物学
最新[2025]版:
大类 | 1 区 生物学
小类 | 1 区 细胞生物学
JCR分区:
出版当年[2019]版:
Q1 CELL BIOLOGY
最新[2023]版:
Q1 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者单位: [1]Tongji Univ, Shanghai East Hosp, Sch Med, Shanghai Inst Stem Cell Res & Clin Translat, Shanghai, Peoples R China
通讯作者:
通讯机构: [1]Tongji Univ, Shanghai East Hosp, Sch Med, Shanghai Inst Stem Cell Res & Clin Translat, Shanghai, Peoples R China [6]Tongji Univ, Shanghai Peoples Hosp 4, Sch Med, Dept Endocrinol & Metab, Shanghai, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:426 今日访问量:2 总访问量:410 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)